tiprankstipranks
Trending News
More News >
Promising Outlook for Exelixis: Buy Rating Backed by Zanzalintinib’s Efficacy and Anticipated Phase III Trial Success
PremiumRatingsPromising Outlook for Exelixis: Buy Rating Backed by Zanzalintinib’s Efficacy and Anticipated Phase III Trial Success
14d ago
Exelixis announces results from expansion cohort of STELLAR-002 trial
Premium
The Fly
Exelixis announces results from expansion cohort of STELLAR-002 trial
15d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
21d ago
Exelixis price target raised to $44 from $38 at TD Cowen
PremiumThe FlyExelixis price target raised to $44 from $38 at TD Cowen
23d ago
Exelixis: Strong Financial Performance and Growth Potential Justify Buy Rating
Premium
Ratings
Exelixis: Strong Financial Performance and Growth Potential Justify Buy Rating
23d ago
Exelixis price target raised to $47 from $40 at Morgan Stanley
Premium
The Fly
Exelixis price target raised to $47 from $40 at Morgan Stanley
23d ago
Exelixis Reports Strong Q1 2025 Financial Performance
PremiumCompany AnnouncementsExelixis Reports Strong Q1 2025 Financial Performance
23d ago
Exelixis: Strong Financial Performance and Promising Pipeline Drive Buy Rating
Premium
Ratings
Exelixis: Strong Financial Performance and Promising Pipeline Drive Buy Rating
24d ago
Exelixis’s Strong Financial Performance and Promising Pipeline Drive Optimistic Outlook and Increased Price Target
Premium
Ratings
Exelixis’s Strong Financial Performance and Promising Pipeline Drive Optimistic Outlook and Increased Price Target
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100